WallStreetZenWallStreetZen

NASDAQ: UTMD
Utah Medical Products Inc Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Utah Medical Products earnings were $10.8M for the trailing 12 months ending Mar 31, 2026, with -10.6% growth year over year. The latest UTMD earnings report on Mar 31, 2026 announced Q1 2026 earnings of $2.6M, up 1.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, UTMD reported annual earnings of $11.3M, with -18.7% growth.

UTMD past earnings growth

How has UTMD's earnings growth performed historically?

Company
-10.58%
Industry
5.03%
Market
83.8%
UTMD's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
UTMD's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
UTMD's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

UTMD earnings history

Current Revenue
$37.5M
Current Earnings
$10.8M
Current Profit Margin
28.9%
UTMD's has not demonstrated consistent... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

UTMD Return on Equity

Current Company
9.1%
Current Industry
8.6%
Current Market
13.5%
UTMD's Return on Equity (9.1%)... subscribe to Premium to read more.
High Return on Equity Performance

UTMD Return on Assets

Current Company
8.9%
Current Industry
7.6%
UTMD is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when UTMD announces earnings.

UTMD Return on Capital Employed

Current Company
11.11%
Current Industry
11%
UTMD's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

UTMD vs Medical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
UTMD$16.41M$10.85M+2.90%$3.38
SMTI-$22.59M-$33.58MN/A-$3.88
PDEX$18.16M$12.00M+13.44%$3.70
EMBC$320.10M$111.90M-26.83%$1.92
KRMD-$1.47M-$2.28MN/A-$0.05
View Top Medical Stocks

Utah Medical Products Earnings Reports & History FAQ

What were Utah Medical Products's earnings last quarter?

On UTMD's earnings call on Invalid Date, Utah Medical Products (NASDAQ: UTMD) reported Q1 2026 earnings per share (EPS) of $0.82, up 10.87% year over year. Total UTMD earnings for the quarter were $2.60 million. In the same quarter last year, Utah Medical Products's earnings per share (EPS) was $0.92.

If you're new to stock investing, here's how to buy Utah Medical Products stock.

Is Utah Medical Products profitable or losing money?

As of the last Utah Medical Products earnings report, Utah Medical Products is currently profitable. Utah Medical Products's net profit (also called net income) for the twelve months ending Mar 31, 2026 was $10.85 million, a 16.28% decrease year over year.

What was UTMD's earnings growth in the past year?

As of Utah Medical Products's earnings date in Invalid Date, Utah Medical Products's earnings has grown -10.58% year over year. This is 15.61 percentage points lower than the US Medical Instruments & Supplies industry earnings growth rate of 5.03%. UTMD earnings in the past year totalled $10.85 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.